Heery Christopher 4
4 · Arcellx, Inc. · Filed Sep 30, 2025
Insider Transaction Report
Form 4
Arcellx, Inc.ACLX
Heery Christopher
CHIEF MEDICAL OFFICER
Transactions
- Sale
Common Stock
2025-09-30$80.55/sh−5,300$426,925→ 16,358 total - Sale
Common Stock
2025-09-30$82.20/sh−1,530$125,763→ 624 total - Sale
Common Stock
2025-09-30$81.46/sh−14,204$1,157,035→ 2,154 total
Footnotes (4)
- [F1]The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 23, 2025.
- [F2]Represents the weighted average share price of an aggregate total of 5,300 shares sold in the price range of $80.00 to $80.90 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Represents the weighted average share price of an aggregate total of 14,204 shares sold in the price range of $81.08 to $82.07 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]Represents the weighted average share price of an aggregate total of 1,530 shares sold in the price range of $82.09 to $82.33 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.